Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100047359Phase 4Recruiting
Phase 4, randomised trial of propofol and sevoflurane in cognitive disorder (CD) and post-operative cognitive decline (POCD) (4 arms), sponsored by Renmin Hospital, Hubei University of Medicine. Primary endpoint: Postoperative cognitive dysfunction. Started Jun 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100047359.